Company Financials

Kuros Biosciences AG Financials

Swiss franc

business Kuros Biosciences AG Company Profile

Main Stock Listing

SIX: KURN

Market Capitalization CHF1.08 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -229.00
Forward PE 70.46
Price to Sales TTM CHF10.35
Price to Book MRQ CHF14.43
Enterprise to Revenue 10.54
Enterprise to EBITDA 187.09

Financial Reports as of Dec. 31, 2013

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2013-12-31
Profit Margin -5.87%
Operating Margin 5.52%
Return on Assets TTM 2.57%
Return on Equity TTM -8.62%

Income Statement

Revenue TTM CHF103,351,000
Revenue per Share TTM CHF2.27
Quarterly Revenue Growth 77.90%
Gross Profit TTM CHF91,677,000
EBITDA CHF5,824,500
Net Income to Common TTM CHF-5,898,000
Diluted EPS TTM CHF-0.15
Quarterly Earnings Growth YoY 0.00%

Balance Sheet

Total Cash MRQ CHF18,442,000
Total Cash per Share MRQ CHF0.46
Total Debt MRQ CHF
Total Debt to Equity MRQ 2.34
Current Ratio MRQ 2.25
Book Value per Share MRQ CHF1.90

Cash Flow

Operating Cash Flow TTM CHF820,000
Levered Free Cash Flow TTM CHF-3,833,125

KURN Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 38,450,129
Float Shares 30,590,756
Avg 10 Volume 111,565
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 27.85%
% Held by Institutions 22.20%

Stock Price Summary

Beta 0.67
Fifty Two Week Low CHF14.00
Fifty Two Week High CHF34.20
Fifty Two Week Change 24.13%
Day 50 MA CHF28.99
Day 200 MA CHF26.12

Dividends and Splits

Forward Annual Dividend Rate CHF
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate CHF0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date 2020-10-08
Ex Dividend Date
Last Split Factor
Last Split Date 2016-06-23